EN DE

AXA SA (CS) Fair Value & Analysis

Financial Services · FR · Market cap €89.5B

AS AXA SA CS · PA
Price€45.05
Fair Value€39.90
Upside-11.4%
Quality67/100
Watch AXA SA for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Solidly profitable · 10.4% net margin
Moderate debt · generates free cash flow
5.24% dividend yield
Mixed vs. peers (7/15)
Moderate moat 45/100
Evidence: High Range €29.93 – €49.89 Share as image

Fair value as of: Aug 13, 2026

From 6 valuation models · updated yesterday

Fair value updated Aug 13, 2026, revised from €62.60 to €39.90 (−36.3%) since Jul 15, 2026. Share price +2.5% over the past month.

A solid business, but screening 11% overvalued on our models.

What matters now

  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
  • Our model range runs from €29.93 (bear) to €49.89 (bull), base €39.90. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 67/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

€45.57 €15.63 Fair Value €39.90 Jun 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range €15.63 – €45.57 · fair‑value band €29.93 – €49.89 · the €45.05 price screens above the €39.90 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

AXA SA (CS) currently trades at €45.05, while our model-based Fair Value estimate is €39.90, implying the stock looks roughly 11.4% overvalued today. The Quality Score stands at 67/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, AXA SA generated revenue of €94.7B at a net margin of 10.4%. Revenue grew 3.2% year over year. It earns a return on equity of 13.4%. The balance sheet holds a net cash position of €6.4B. Fundamentals as of Aug 13, 2026

Our scenario range runs from €29.93 (bear case) to €49.89 (bull case); at €45.05, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 31% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -33% fair-value upside, at -11%, CS screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income €30.70 €39.12 €130.04 76
Gordon GGM €21.34 €34.95 €50.62 70
P/E Multiple €46.95 €62.60 €78.26 63
All 6 models by family
Dividend Discount
Gordon GGM €21.34 €34.95 €50.62 70
DDM Multi-Stage €21.34 €31.20 €42.21 61
Multiples
P/E Multiple €46.95 €62.60 €78.26 63
P/B Multiple €24.36 €32.48 €40.60 55
Asset-Based
NCAV (Graham) €11.60 €15.54 €23.20 50
Economic Profit
Residual Income €30.70 €39.12 €130.04 76

Widest divergence: Economic Profit (€39.12) versus Asset-Based (€15.54). Highest evidence: Residual Income (76).

Notify me when CS reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) €94.7B
Revenue growth (YoY) +3.2%
Net margin 10.4%
Return on equity 13.4%
Free cash flow €21.1B FY2025
P/E ratio 13.2
More key figures
Operating margin 10.5%
EPS (TTM) €3.42
Dividend yield 5.8%
EPS growth (YoY) +59.8%
Net cash €6.4B FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 67/100

Of which business quality 60 · Market factors (momentum, volatility) 73

Profitability 36
Margins and returns on capital today
Quality Growth 57
Are margins and returns improving?
Cashflow 86
Earnings quality: real cash, not paper profit
Fin. Strength 12
Balance sheet, leverage, solvency risk
Investment 98
Disciplined investing over empire-building
Low Volatility 93
Calm price path (market factor)
Momentum 60
Price trend over the last 3–12 months (market factor)
52W Momentum 73
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

AXA SA, through its subsidiaries, insurance, asset management, and banking services worldwide. The company operates through France, Europe, AXA XL, Asia, Africa & EME-LATAM, and Transversal & Other segments. It offers life and savings insurance and property and casualty insurance products.

Full company description

AXA SA, through its subsidiaries, insurance, asset management, and banking services worldwide. The company operates through France, Europe, AXA XL, Asia, Africa & EME-LATAM, and Transversal & Other segments. It offers life and savings insurance and property and casualty insurance products. The company also provides protection and retirement products for individual and professional customers; reinsurance coverages; property, primary and excess casualty, excess and surplus lines, environmental liability, professional liability, construction, marine, energy, aviation and satellite, fine art and specie, livestock and aquaculture, accident and health, and crisis management. In addition, it offers reinsurance solutions with casualty, property risk, property catastrophe, specialty, and other reinsurance; proportional and non-proportional, and facultative reinsurance; risk management solutions and consulting services; integrated ecosystem between healthcare solutions and the insurance coverage, which includes onsite services in clinics, remote teleconsultation and digital services, and home services; travel insurance and assistance services, as well as AXA Multilink platform, a B2B2C platform; Sophia, the customer facing GenAI chatbot; and EMMA, a digital assistant. Further, the company offers motor, household, property and general liability, banking, savings, health, term life, whole life, universal life, endowment, deferred and immediate annuities, and other investment-based products for retail/individual and commercial/group customers. AXA SA was founded in 1852 and is headquartered in Paris, France.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

AXA SA reported revenue of €116B in FY2025 versus €122B in FY2021, a compound −1.4%/yr. Reported net income was €9.8B in FY2025, compounding +7.7%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
€116B
Latest YoY
+28.6%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.7%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+0.6%
Avg. growth/yr (30Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.4%
Revenue −1.4%/yr
FY21 €122B
FY22 €104B
FY23 €86.0B
FY24 €89.8B
FY25 €116B
Net income +7.7%/yr
FY21 €7.3B
FY22 €6.7B
FY23 €7.2B
FY24 €7.9B
FY25 €9.8B
Character of growth · EPS growth decomposed (2014-2025) +6.0 % p.a.
Revenue per share −1.2 pp

of which total revenue −2.4 pp · buybacks/dilution +1.2 pp

EBIT margin +4.4 pp
Tax rate +0.9 pp
Residual (interest, one-offs) +1.8 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

CS screens 11% overvalued. Compare with Berkshire Hathaway Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "AXA SA Fair Value". https://www.fairvalue-calculator.com/stock/CS

Peer Group

Insurance - Diversified · 84 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 64 · Above median
Fair Value upside −11% · Above median
Return on equity (TTM) 13% · Above median
Return on assets 1% · Below median
Net margin (TTM) 10% · Above median
Operating margin (TTM) 11% · Below median
Revenue growth 3% · Below median
Dividend yield (TTM) 5.2% · Top 25%
Debt / equity 1.28× · Higher than 75% of peers

Valuation Multiples vs Insurance - Diversified median · lower = cheaper

P/E (TTM) 13.2× · Pricier than median
P/B 2.19× · Pricier than 75% of peers
P/S (TTM) 1.09× · Pricier than median
P/FCF 4.9× · Pricier than median
EV/EBITDA 11.9× · Pricier than 75% of peers
PEG 1.21× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 19 · sector 18
FUTURE 16 · sector 31
PAST 54 · sector 49
HEALTH 36 · sector 89
DIVIDEND 100 · sector 44

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Insurance - Diversified stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Berkshire Hathaway Inc BRKB 8,562 MXN 10,429 MXN +22%
Allianz SE ALV €437.80 €266.04 -39%
Zurich Insurance Group ZURN CHF 589.20 CHF 392.99 -33%
Assicurazioni Generali S.p.A G €43.88 €13.91 -68%
BB Seguridade Participações S.A BBSE3 R$37.26 R$33.94 -9%
Tryg A/S TRYG kr 151.70 kr 67.88 -55%
PT Sinar Mas Multiartha Tbk SMMA 20,175 IDR 4,617 IDR -77%
ICICI Lombard General Insurance Company ICICIGI ₹1,635 ₹589.67 -64%
The New India Assurance Company NIACL ₹181.09 ₹128.57 -29%
Seoul Guarantee Insurance Co 031210 44,150 KRW 56,679 KRW +28%

Compare AXA SA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is AXA SA (CS) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of €39.90 versus a price of €45.05, about −11% (overvalued).
What is the fair value of CS?
Our model-based fair value for AXA SA is €39.90 (as of Aug 13, 2026), built from audited fundamentals. The current price is €45.05.
What is the quality score of CS?
AXA SA has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of AXA SA (CS)?
AXA SA reported trailing-twelve-month revenue of about €94.7B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of CS?
The net profit margin of AXA SA is about 10.4%, meaning it keeps roughly 10.4% of revenue as net income. Based on the latest reported figures.
Does AXA SA pay a dividend?
AXA SA currently shows a dividend yield of about 5.84% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track AXA SA and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.